Supreme Court Shields Pesticide Makers from State Failure-to-Warn Claims
High court ruling strengthens federal preemption defense for Bayer and could reshape pesticide litigation nationwide
The U.S. Supreme Court handed Bayer a significant legal victory by ruling that federal law pre-empts state-law failure-to-warn claims involving its Roundup herbicide, a decision that could dramatically reduce the company’s future legal exposure while extending similar protections to other pesticide manufacturers. The ruling, supported by the Trump administration, concludes that when the U.S. Environmental Protection Agency has approved a pesticide’s labeling under federal law, manufacturers generally cannot be held liable under state law for failing to include additional cancer warnings. The decision effectively undercuts one of the primary legal theories that has fueled years of litigation over Roundup and resulted in billions of dollars in jury verdicts and settlements against Bayer.
The ruling was 7-2 in favor of Monsanto/Bayer.
Majority: 7 justices ruled that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) pre-empts state-law “failure-to-warn” claims when the U.S. Environmental Protection Agency has approved a pesticide label and has not required a cancer warning. Justice Brett Kavanaugh wrote the majority opinion.
Dissent: Justice Ketanji Brown Jackson wrote the dissent, joined by Justice Neil Gorsuch. The dissent argued that Congress did not clearly intend FIFRA to eliminate traditional state-law remedies for individuals claiming injury from pesticides.
Legal holding: The Court concluded that because EPA repeatedly determined that Roundup’s label should not contain a cancer warning, allowing state juries to impose liability for the absence of such a warning would conflict with the federal labeling scheme established under FIFRA.
Practical effect: The decision is expected to result in the dismissal of thousands of pending failure-to-warn lawsuits against Bayer and could provide the same defense to other pesticide manufacturers whose products carry EPA-approved labels. However, the ruling does not necessarily bar every pesticide lawsuit; claims based on other legal theories, such as defective design or manufacturing defects, may still proceed depending on the facts of each case.
The lineup was notable because Justice Gorsuch, often part of the Court’s conservative majority, joined Justice Jackson’s dissent, making it one of the relatively uncommon 7-2 decisions in which a conservative justice broke with the majority.
The ruling represents a major shift in the balance between federal regulatory authority and state tort law. Bayer and other pesticide manufacturers have long argued that it is impossible to comply simultaneously with EPA-approved labeling requirements and state jury verdicts demanding additional warnings. The Supreme Court agreed that allowing states to impose different warning requirements would undermine the uniform federal regulatory framework established under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA).
For Bayer, the decision removes a major legal overhang that has weighed on the company since its acquisition of Monsanto in 2018. Although the company has already paid or reserved tens of billions of dollars to resolve Roundup-related claims, thousands of lawsuits remained pending. Investors are likely to view the ruling as significantly reducing future litigation risk and improving the company’s financial outlook.
The decision also has broader implications for the agricultural chemical industry. Manufacturers of herbicides, insecticides and fungicides are expected to rely on the ruling as a defense against future state-law warning claims, potentially limiting litigation across the sector. Agricultural organizations have generally argued that uniform federal labeling standards provide greater regulatory certainty and help ensure continued access to crop protection tools that farmers depend upon.
Consumer advocates and plaintiffs’ attorneys, however, contend the ruling leaves individuals who believe they were harmed by pesticide exposure with few remaining legal remedies. They argue that the decision places greater weight on EPA’s scientific determinations than on state courts and juries, even as debate continues over the potential health risks associated with glyphosate, Roundup’s active ingredient. The ruling is therefore expected to intensify pressure on EPA and Congress from both supporters and critics of pesticide regulation, as future disputes over pesticide safety are likely to shift increasingly from the courtroom to the regulatory and legislative arenas.
